NEW YORK (GenomeWeb News) – Oxford Gene Technology said today that it has been working with Emory Genetics Laboratory to develop a menu of comparative genomic hybridization arrays focused on a variety of genetic disorders.

Together, the Oxford, UK-based company and EGL have designed more than 20 such chips, which enable the detection of copy number variants in genes associated with cardiovascular, inherited eye, intellectual disability, and neuromuscular disorders, as well as a range of inherited cancers.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.

Sponsored by
Dovetail Genomics

Proximity ligation technology generates multi-dimensional next-generation sequencing data that is proving to solve unmet needs in genomic research. 

Sponsored by
Horizon Discovery

This webinar will provide an in-depth case study demonstrating how reference standards can be used to develop and validate circulating tumor DNA (ctDNA)-based assays.

Sponsored by
Dovetail Genomics

This webinar will discuss a proximity ligation-based method for studying structural variation in formalin-fixed paraffin-embedded (FFPE) tissue.